IP Library › Granted Patent US 12,540,316
Granted Patent B2
US 12,540,316 · App. 17/931,280 · Granted Feb 3, 2026

Polypeptides having protease activity and polynucleotides encoding same

Inventor: Tine Hoff (Holte, DK)
Assignee: Novozymes A/S
C12N9/54A23K10/14A23K20/147A23K20/174A23K20/189A23K20/20C07K2319/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,540,316
App. No.
17/931,280
Granted
Feb 3, 2026
Kind
B2
Abstract

The present invention relates to isolated polypeptides having protease activity, animal feed additives comprising said polypeptides improving the nutritional value of an animal feed by adding the protease. invention also relates to polynucleotides encoding the polypeptides, nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing the polypeptides.

Claims (19)

1 . A nucleic acid construct or expression vector comprising a polynucleotide encoding a polypeptide having protease activity operably linked to one or more control sequences that direct the production of the polypeptide in an expression host,

wherein the polypeptide has at least 98% sequence identity to amino acids 26-425 of SEQ ID NO: 1 or wherein the polypeptide is a fragment of amino acids 26-425, wherein the polypeptide optionally further comprises an N-terminal and/or C-terminal His-tag and/or HO-tag and/or the polypeptide optionally further comprises an N-terminal and/or C-terminal extension of up to 10 amino acids.

2 . A recombinant host cell comprising a polynucleotide encoding a polypeptide having protease activity operably linked to one or more control sequences that direct the production of the polypeptide,

wherein the polypeptide has at least 98% sequence identity to amino acids 26-425 of SEQ ID NO: 1 or wherein the polypeptide is a fragment of amino acids 26-425, wherein the polypeptide optionally further comprises an N-terminal and/or C-terminal His-tag and/or HO-tag and/or the polypeptide optionally further comprises an N-terminal and/or C-terminal extension of up to 10 amino acids.

3 . The recombinant host cell of claim 2 , wherein the polypeptide has at least 98% sequence identity to amino acids 26-425 of SEQ ID NO: 1.

4 . The recombinant host cell of claim 2 , wherein the polypeptide has at least 99% sequence identity to amino acids 26-425 of SEQ ID NO: 1.

5 . The recombinant host cell of claim 2 , wherein the polypeptide has at least 99.5% sequence identity to amino acids 26-425 of SEQ ID NO: 1.

6 . The recombinant host cell of claim 2 , wherein the polypeptide comprises amino acids 26-425 of SEQ ID NO: 1.

7 . The recombinant host cell of claim 2 , wherein the polypeptide is a fragment of amino acids 26-425 of SEQ ID NO: 1, wherein the fragment has protease activity.

8 . The recombinant host cell of claim 2 , wherein the polypeptide further comprises an N-terminal and/or C-terminal His-tag and/or HQ-tag.

9 . The recombinant host cell of claim 2 , wherein the polypeptide further comprises an N-terminal and/or C-terminal extension of up to 10 amino acids.

10 . The recombinant host cell of claim 2 , which is a yeast recombinant host cell selected from the group consisting of Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces , and Yarrowia cells.

11 . The recombinant host cell of claim 2 , which is a filamentous fungal recombinant host cell selected from the group consisting of Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phlebia, Piromyces, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trametes , and Trichoderma cells.

12 . The recombinant host cell of claim 2 , which is a Gram-positive cell selected from the group consisting of Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Oceanobacillus, Staphylococcus, Streptococcus , or Streptomyces cells, or a Gram-negative bacteria selected from the group consisting of Campylobacter, E. coli, Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Neisseria, Pseudomonas, Salmonella , and Ureaplasma cells.

13 . A method of producing a polypeptide having protease activity, comprising cultivating a recombinant host cell of claim 12 under conditions conducive for production of the polypeptide.

14 . The method of claim 13 , further comprising recovering the polypeptide.

15 . The recombinant host cell of claim 2 , which is selected from the group consisting of Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus firmus, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus megaterium, Bacillus pumilus, Bacillus stearothermophilus, Bacillus subtilis, Bacillus thuringiensis, Streptococcus equisimilis, Streptococcus pyogenes, Streptococcus uberis , and Streptococcus equi subsp. Zooepidemicus, Streptomyces achromogenes, Streptomyces avermitilis, Streptomyces coelicolor, Streptomyces griseus , and Streptomyces lividans cells.

16 . A method of producing a polypeptide having protease activity, comprising cultivating a recombinant host cell of claim 15 under conditions conducive for production of the polypeptide.

17 . The method of claim 16 , further comprising recovering the polypeptide.

Priority Claims (1)
EP 18192131 · Aug 31, 2018 · regional
Continuity (2)
Division 17264540
Related Publication 20220411775A1 · Dec 29, 2022
References Cited (16)
US 20030021774A1 · Sjoeholm et al. · 2003 [cited by applicant]
US 20040202697A1 · Beauchemin · 2004 [cited by applicant]
US 20140206594A1 · Borchert et al. · 2014 [cited by applicant]
US 20160298102A1 · Gjermansen et al. · 2016 [cited by applicant]
US 20180192668A1 · Le · 2018 [cited by applicant]
US 20210332343A1 · Hoff · 2021 [cited by applicant]
WO 2008124819A1 · 2008 [cited by applicant]
WO 2015091989A1 · 2015 [cited by applicant]
WO 2019043191A1 · 2019 [cited by applicant]
Bowie et al (Science, 1990, 257:1306-1310). [cited by examiner]
Burgess et al (J. of Cell Bio. 111:2129-2138, 1990). [cited by examiner]
Lazar et al. (Molecular and Cellular Biology, 1988, 8:1247-1252). [cited by examiner]
Anonymous, UniParc Accession No. UPI0002081292 (2011). [cited by applicant]
Doyle, GenBank Accession No. SUV01564 (2018). [cited by applicant]
Myscofski et al., Protein Expression and Purification, vol. 20, pp. 112-123 (2000). [cited by applicant]
Neveu et al., UniProt Accession No. F4ZE70 (2011). [cited by applicant]